支气管内活瓣治疗后气胸的危险因素:一项队列研究
该回顾性全国队列研究纳入丹麦2017至2023年接受支气管内活瓣治疗的228例慢阻肺伴肺气肿患者,46例(20.2%)发生气胸。上叶治疗、高靶肺叶容积和高残气量是气胸独立危险因素,气胸患者肺炎和ICU入住风险显著更高。
要点
- 上叶EBV治疗气胸风险显著高于下叶(调整RR 6.32)。
- 高靶肺叶容积和高残气量是气胸独立危险因素。
- 气胸患者肺炎和ICU入住风险显著增加。
核心结论
- EBV治疗上叶、高残气量和高靶肺叶容积时气胸更常见,导致住院延长和医院获得性肺炎风险。
研究设计与样本
- 回顾性全国队列研究,纳入丹麦所有EBV中心2017至2023年治疗的228例慢阻肺伴肺气肿患者。
主要发现
- 228例中46例(20.2%)发生气胸,中位发生时间7小时(IQR 2-22),中位引流时间13天(IQR 8.5-22)。
- 上叶EBV治疗气胸风险显著高于下叶(调整RR 6.32,95%CI 2.56-15.60)。
- 靶肺叶容积每增加100mL气胸风险独立增高(调整OR 1.12,95%CI 1.02-1.22)。
- 残气量每增加10%气胸风险独立增高(调整OR 1.11,95%CI 1.01-1.23)。
- 气胸患者肺炎风险(RR 4.5,95%CI 1.7-11.8)、脓胸风险(p=0.0047)和ICU入住风险(RR 9.89,95%CI 1.98-49.4)显著更高。
临床怎么用
- 对接受EBV治疗的上叶病变、高残气量或高靶肺叶容积患者应加强气胸监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Pneumothorax (PTX) is the most prevalent and serious adverse event associated with endobronchial valve (EBV) treatment in chronic obstructive pulmonary disease (COPD) with emphysema. This study aimed to compare preoperative characteristics and 30-day outcomes in patients with COPD with and without PTX. METHOD: This retrospective nationwide cohort study included patients treated with EBV between 2017 and 2023 at all EBV centres in Denmark. Data were retrieved from medical records. RESULTS: A total of 228 patients were included, of whom 46 (20.2%) had PTX. The median time to PTX was 7 h (IQR 2-22) and the median drain treatment duration was 13 days (IQR 8.5-22). The risk of PTX was significantly higher when EBV treatment was performed in the upper lobes than in the lower lobes (adjusted RR 6.32, 95% CI 2.56-15.60). High target lobe volume (adjusted OR pr 100 mL increase 1.12, 95% CI 1.02-1.22) and high residual volume (adjusted OR pr 10%pt. increase 1.11, 95% CI 1.01-1.23) were independent risk factors for PTX. More PTX patients had atelectasis after 2 h compared to patients without PTX. The risk of pneumonia (RR 4.5, 95% CI 1.7-11.8), empyema (p = 0.0047) and ICU admission (RR 9.89, 95% CI 1.98-49.4) were significantly higher in the PTX patients than in the patients without PTX. CONCLUSIONS: PTX was more prevalent when EBV treatment was performed in the upper lobes and with high residual volume and target lobe volume, leading to prolonged hospital admission and risk of hospital-acquired pneumonia.
引用
- Jørgensen KH, Christensen TD, Titlestad IL, et al. Risk Factors for Pneumothorax After Treatment With Endobronchial Valves: A Cohort Study. Respirology. 2025. PMID: 40442057. doi:10.1111/resp.70069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。